ReactWise Raises $3.4M in Pre-Seed Round

ReactWise Raises $3.4M in Pre-Seed Round

ReactWise, a London, UK-based startup leveraging AI to optimize chemical processes in drug manufacturing, has raised $3.4 million in pre-seed funding.

The round includes investments from Y Combinator, Innovate UK, and other venture capitalists and angel investors.

The company will use the funds to develop its AI-driven chemical manufacturing platform further, enhance its machine-learning models, and support ongoing work with pharmaceutical companies through pilot trials.

Founded in 2024, ReactWise is a SaaS company specializing in AI-driven chemical process optimization for the pharmaceutical industry. The company develops software that accelerates the scaling-up of drug production by using AI and machine learning to optimize chemical manufacturing processes. ReactWise's AI models, trained on a vast dataset of chemical reactions, provide pharmaceutical companies with instant, data-backed recommendations for efficient drug manufacturing.

Funding Details

Company: ReactWise Technologies Ltd.

Raised: $3.4M

Round: Pre-Seed

Funding Date: March 2025

Investors: Y Combinator, Innovate UK

Company Website: https://www.reactwise.com/

Software Category: AI-Driven Chemical Manufacturing